The Essential Guide to Prescription Drugs, 12 Top Meds for 2012 now available in full color printed and on Kindle
The Essential Guide to Prescription Drugs, 12 Top Meds for 2012 is now available from Amazon in a full-color printed version.
Dr. Rybacki to be a guest on Conversations with Peter Solomon WIP, 94.1 FM April 8th 7:30 AM to 8 AM
I'll be a guest on Conversations with Peter solomon on WIP AM and FM (94.1 FM) in Philadelphia, Sunday, April 8th from 7:30 AM to 8 AM.
The first of a new kind of lab test and a first-in-the-class therapy have been approved by the FDA. Zelboraf (vemurafenib) was approved by the FDA under the priority review program.
A medicine which first received notariety at the American Society of Clinical Oncologists (ASCO) this summer was approved by the FDA today. This drug is the first in a new family of medicines called anti-CTLA 4 inhibitors.
Activatng the immune system is a relatively new model for attacking cancer, but it appears to be coming of age. While "true breakthrough" is a term rarely applied in most treatments, ipilimumab (proposed brand-Yervoy) may be just that for patients with melanoma.